Health Care Transaction Laws Unwrapped: Navigating Expanding Government Oversight of Health Care Investments
Description
Ropes & Gray is pleased to introduce our latest podcast series, Health Care Transaction Laws Unwrapped, which continues our exploration of critical developments in health care regulation of health care transactions. In this six-part series, our team will delve into the evolving landscape of state health care transaction laws and their implications for health care entities and private equity investors. In this introductory episode, Ropes & Gray health care partners Debbie Gersh, Tim McCrystal and Jenn Romig analyze the current regulatory climate and its implications for investments in health care, including:
Federal oversight: recent federal initiatives, including the FTC’s workshop and the impact of new legislation targeting private equity.State regulations: an overview of expanding state-level health care transaction laws, including notable developments in Massachusetts, California, New York and the Midwest.Enforcement trends: insights into how these regulations are being enforced, and their impact on deal timelines and administrative costs.Strategic implications: how investors can navigate these new requirements, potential challenges, and strategies for adapting to this regulatory environment.
On this episode of Ropes & Gray’s podcast series Non-binding Guidance, health care partner David Peloquin and life sciences regulatory and compliance counsel Sarah Blankstein discuss the FDA's recent draft guidance on diversity action plans (DAPs) aimed at improving the enrollment of...
Published 11/19/24
On this episode of Ropes & Gray’s podcast series Controlling Opinions, Josh Oyster, a partner in the life sciences regulatory and compliance practice group, is joined by colleagues Andrew O’Connor, a litigation and enforcement partner, and Beth Weinman, life sciences regulatory and compliance...
Published 11/18/24